NCT01093612View on ClinicalTrials.gov

Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 16, 2011

Primary Completion Date

October 23, 2018

Study Completion Date

August 26, 2025

Conditions
Breast CancerStage IV Breast Cancer
Interventions
PROCEDURE

positron emission tomography

PET images performed on a GE Discovery 16 Ste PET-CT scanner

RADIATION

copper Cu 64-DOTA-trastuzumab

15 mCi of Cu 64-DOTA-trastuzumab, total trastuzumab dose less than 5 mg.

PROCEDURE

Biopsy

Correlative Studies

OTHER

Immunohistochemistry staining method

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

GENETIC

mutation analysis

Correlative studies

Trial Locations (1)

91010

City of Hope, Duarte

All Listed Sponsors
lead

City of Hope Medical Center

OTHER